TrialClinical drug investigation2018

Long-Term Response and Remission with Pixantrone in Patients with Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma: Post-Hoc Analysis of the Multicenter, Open-Label, Randomized PIX301 Trial.

Ruth Pettengell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.